Innovation funnel for covid-19 - validation center

Active Awarded Last action

Contract number
75N92023F00001
Awardee
Awarding agency
Obligated
$41,200,000

Award facts

Opportunity
  • 75N92023R0182 Solicitation number
Contract value 100% obligated
$41,200,000.00 Current and potential, with all options
Completion date 89% complete
Current and potential, with all options
Funding agency
National Institute of Biomedical Imaging and Bioenginering National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30322, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $41,200,000

About this award

Emory University received a $41.2 million firm fixed-price delivery order from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) for the Innovation Funnel for COVID-19 Validation Center, with performance in Atlanta, Georgia and completion targeted for March 26, 2027. The award was made without set-aside designation on March 27, 2023, recognizing Emory's established expertise as a premier research institution in biomedical research, infectious disease studies, and clinical trial execution. Emory's Office of Sponsored Programs will execute this work, leveraging the university's demonstrated capabilities in complex federal research projects and its extensive portfolio of awards across the National Institutes of Health and other federal agencies.

Children's Healthcare of Atlanta, Inc., a pediatric healthcare provider, serves as a major subcontractor on this engagement, awarded a subcontract effective October 16, 2023 for COVID-19 validation services. The collaboration between Emory University and Children's Healthcare of Atlanta combines academic research infrastructure with clinical expertise to support the validation center's mission. This contract structure aligns with NIBIB's focus on advancing biomedical imaging and bioengineering technologies, particularly in the context of pandemic preparedness and response capabilities developed through innovation funnel evaluation processes.

Quick answers

Who was awarded contract 75N92023F00001?

75N92023F00001 was awarded to Emory University by National Heart Lung and Blood Institute (National Institutes of Health) on March 27, 2023.

How much is contract 75N92023F00001 worth?

The government has obligated $41,200,000 on 75N92023F00001.

Which agency awarded contract 75N92023F00001?

National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92023F00001, with funding from National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health).

Is contract 75N92023F00001 an order under another contract?

Yes. 75N92023F00001 is a delivery order under 75N92022D00015, an indefinite delivery contract.

Was contract 75N92023F00001 competed?

The extent of competition for 75N92023F00001 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award